CN105456421A - 治疗白血病的中药组合物 - Google Patents
治疗白血病的中药组合物 Download PDFInfo
- Publication number
- CN105456421A CN105456421A CN201510912367.5A CN201510912367A CN105456421A CN 105456421 A CN105456421 A CN 105456421A CN 201510912367 A CN201510912367 A CN 201510912367A CN 105456421 A CN105456421 A CN 105456421A
- Authority
- CN
- China
- Prior art keywords
- placenta hominis
- grams
- paeoniae alba
- radix paeoniae
- fructus psoraleae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 35
- 206010024324 Leukaemias Diseases 0.000 title abstract description 12
- 239000003814 drug Substances 0.000 claims abstract description 68
- 210000002826 Placenta Anatomy 0.000 claims abstract description 58
- 229940079593 drugs Drugs 0.000 claims abstract description 43
- 230000000694 effects Effects 0.000 abstract description 4
- 241000157373 Uncaria rhynchophylla Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 26
- 238000011084 recovery Methods 0.000 description 21
- 210000004369 Blood Anatomy 0.000 description 8
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N Psoralen Chemical compound data:image/svg+xml;base64,<?xml version='1.0' encoding='iso-8859-1'?>
<svg version='1.1' baseProfile='full'
              xmlns='http://www.w3.org/2000/svg'
                      xmlns:rdkit='http://www.rdkit.org/xml'
                      xmlns:xlink='http://www.w3.org/1999/xlink'
                  xml:space='preserve'
width='300px' height='300px' viewBox='0 0 300 300'>
<!-- END OF HEADER -->
<rect style='opacity:1.0;fill:#FFFFFF;stroke:none' width='300.0' height='300.0' x='0.0' y='0.0'> </rect>
<path class='bond-0 atom-0 atom-1' d='M 125.4,194.5 L 162.4,168.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-0 atom-0 atom-1' d='M 125.8,183.3 L 151.7,165.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-10 atom-0' d='M 84.6,175.3 L 125.4,194.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1 atom-1 atom-2' d='M 162.4,168.9 L 175.4,175.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1 atom-1 atom-2' d='M 175.4,175.0 L 188.5,181.2' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-7 atom-1' d='M 158.7,124.0 L 162.4,168.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-2 atom-3' d='M 217.1,178.5 L 228.7,170.5' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-2 atom-3' d='M 228.7,170.5 L 240.2,162.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-3 atom-4' d='M 238.3,166.5 L 251.3,172.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-3 atom-4' d='M 251.3,172.7 L 264.3,178.9' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-3 atom-4' d='M 242.1,158.4 L 255.2,164.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-3 atom-4' d='M 255.2,164.5 L 268.2,170.7' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-3 atom-5' d='M 240.2,162.5 L 236.5,117.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-5 atom-5 atom-6' d='M 236.5,117.5 L 195.8,98.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-5 atom-5 atom-6' d='M 226.5,122.8 L 198.0,109.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-6 atom-7' d='M 195.8,98.3 L 158.7,124.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-7 atom-8' d='M 158.7,124.0 L 118.0,104.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-7 atom-8' d='M 148.7,129.2 L 120.2,115.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8 atom-8 atom-9' d='M 118.0,104.7 L 80.9,130.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-9 atom-10' d='M 80.9,130.4 L 84.6,175.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-9 atom-10' d='M 90.4,136.4 L 93.0,167.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-15 atom-13 atom-9' d='M 37.0,120.0 L 80.9,130.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-10 atom-11' d='M 84.6,175.3 L 71.2,180.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-10 atom-11' d='M 71.2,180.9 L 57.9,186.5' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-11 atom-12' d='M 31.5,179.3 L 22.6,168.9' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-11 atom-12' d='M 22.6,168.9 L 13.6,158.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-12 atom-13' d='M 13.6,158.5 L 37.0,120.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-12 atom-13' d='M 24.9,157.4 L 41.2,130.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<text x='197.7' y='197.1' class='atom-2' style='font-size:18px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='275.5' y='190.7' class='atom-4' style='font-size:18px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='37.6' y='201.7' class='atom-11' style='font-size:18px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
</svg>
 data:image/svg+xml;base64,<?xml version='1.0' encoding='iso-8859-1'?>
<svg version='1.1' baseProfile='full'
              xmlns='http://www.w3.org/2000/svg'
                      xmlns:rdkit='http://www.rdkit.org/xml'
                      xmlns:xlink='http://www.w3.org/1999/xlink'
                  xml:space='preserve'
width='85px' height='85px' viewBox='0 0 85 85'>
<!-- END OF HEADER -->
<rect style='opacity:1.0;fill:#FFFFFF;stroke:none' width='85.0' height='85.0' x='0.0' y='0.0'> </rect>
<path class='bond-0 atom-0 atom-1' d='M 35.0,54.5 L 45.5,47.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-0 atom-0 atom-1' d='M 35.1,51.3 L 42.4,46.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-10 atom-0' d='M 23.4,49.1 L 35.0,54.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1 atom-1 atom-2' d='M 45.5,47.3 L 50.2,49.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1 atom-1 atom-2' d='M 50.2,49.5 L 54.9,51.7' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-7 atom-1' d='M 44.4,34.5 L 45.5,47.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-2 atom-3' d='M 59.1,51.2 L 63.3,48.3' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-2 atom-3' d='M 63.3,48.3 L 67.5,45.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-3 atom-4' d='M 66.9,46.6 L 71.6,48.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-3 atom-4' d='M 71.6,48.8 L 76.3,51.0' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-3 atom-4' d='M 68.0,44.3 L 72.7,46.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-3 atom-4' d='M 72.7,46.5 L 77.4,48.7' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-3 atom-5' d='M 67.5,45.4 L 66.4,32.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-5 atom-5 atom-6' d='M 66.4,32.7 L 54.9,27.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-5 atom-5 atom-6' d='M 63.6,34.2 L 55.5,30.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-6 atom-7' d='M 54.9,27.3 L 44.4,34.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-7 atom-8' d='M 44.4,34.5 L 32.9,29.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-7 atom-8' d='M 41.6,36.0 L 33.5,32.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8 atom-8 atom-9' d='M 32.9,29.1 L 22.4,36.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-9 atom-10' d='M 22.4,36.4 L 23.4,49.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-9 atom-10' d='M 25.1,38.1 L 25.8,47.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-15 atom-13 atom-9' d='M 10.0,33.4 L 22.4,36.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-10 atom-11' d='M 23.4,49.1 L 18.6,51.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-10 atom-11' d='M 18.6,51.1 L 13.8,53.1' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-11 atom-12' d='M 9.9,51.9 L 6.6,48.1' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-11 atom-12' d='M 6.6,48.1 L 3.4,44.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-12 atom-13' d='M 3.4,44.3 L 10.0,33.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-12 atom-13' d='M 6.5,44.0 L 11.2,36.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<text x='55.2' y='55.7' class='atom-2' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='77.2' y='53.9' class='atom-4' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='9.9' y='57.0' class='atom-11' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
</svg>
 C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 210000003734 Kidney Anatomy 0.000 description 5
- 210000004185 Liver Anatomy 0.000 description 3
- 210000000582 Semen Anatomy 0.000 description 3
- 210000000278 Spinal Cord Anatomy 0.000 description 3
- 210000001185 Bone Marrow Anatomy 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- 208000005209 Hematologic Disease Diseases 0.000 description 2
- 229940097275 Indigo Drugs 0.000 description 2
- 240000007871 Indigofera tinctoria Species 0.000 description 2
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 2
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000003211 malignant Effects 0.000 description 2
- 210000000056 organs Anatomy 0.000 description 2
- 230000001225 therapeutic Effects 0.000 description 2
- 210000001519 tissues Anatomy 0.000 description 2
- 241001116389 Aloe Species 0.000 description 1
- 208000007502 Anemia Diseases 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 210000000988 Bone and Bones Anatomy 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- 241000005787 Cistanche Species 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 241001489978 Eupolyphaga Species 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- 206010018987 Haemorrhage Diseases 0.000 description 1
- 210000003958 Hematopoietic Stem Cells Anatomy 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000007046 Leukemia, Myeloid, Acute Diseases 0.000 description 1
- 241000283956 Manis Species 0.000 description 1
- 206010028570 Myelopathy Diseases 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241000195474 Sargassum Species 0.000 description 1
- 206010061367 Spinal cord disease Diseases 0.000 description 1
- 210000000952 Spleen Anatomy 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 235000005035 ginseng Nutrition 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 230000002607 hemopoietic Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000001737 promoting Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001502 supplementation Effects 0.000 description 1
Abstract
<b>本发明涉及一种治疗白血病的中药组合物，该中药组合物包括胎盘，狗脊，补骨脂，钩藤和白芍。该种治疗白血病的中药组合物是以胎盘为主药，内服主药和其它药物组合后对治疗白血病的效果非常理想，痊愈率达到</b><b>100%</b><b>。</b>
Description
技术领域
[0001]本发明涉及一种用于治疗白血病的中药组合物。
背景技术
[0002]白血病是造血干细胞异常的克隆性恶性疾病，且在骨髓和其他造血组织中呈恶性克隆性增生、积聚，并浸润其他器官和组织，临床表现为贫血、出血、感染及各器官浸润症状。为此，西医认白血病定位骨髓病，其治疗的主要方式是换骨髓，而中医认为白血病是肾主骨生髓是肾脏主骨髓功能下降造成的。在现有技术中，对于被称为“不治之症”的白血病，中医有以下四种辅助治疗的中药药剂:1、生石膏、生地、青黛、黄连、虎杖、丹参、苦参、丹皮、银花;2、黄连、芦荟、龙胆草、青黛、大黄、莪术、黄药子、夏枯草、柴胡，该种药剂清肝泻火佐以活血化瘀，适用于湿热型白血病;3、穿山甲、土鳖虫、昆布、海藻、鳖甲；4、太子参、麦冬、五味子、半夏、茯苓、陈皮、杏仁，该种药剂的功能益气养阴，健脾化痰，适用于急性非淋巴细胞性白血病。虽然上述的四种中药可治疗白血病的一小部分，但白血病患者不在医生的指导下服用，其盲目用药可因不对症而延误治疗，所以，上述的四种中药达不到理想的治疗效果O
[0003]中国专利102210820A号公开的名称为“一种治疗白血病的中药组合物”包括女贞子，五味子，芦根，夏枯草，山药，补骨脂，肉苁蓉，杜仲，旱莲草，桑椹子，白芍，赤芍，知母，青蒿，生地黄，熟地，玉竹，当归，黄苗，甘草，双花，桃仁，茯苳，白术，红率，枸紀子，红小豆，苍术，灵芝，元参，大黄，冬虫夏草，人参，西洋参，藏红花，白芨，红景天，三七，鳖甲，蛇莓，鹿脊髓这41种中药。虽然该中药组合物中采用补骨脂进行补骨生髓，而采用白芍进行补血，但因没有采用治脊髓血液疾病的药物，所以，食用该种中药治疗白血病能否彻底治愈且长期不复发还有待于进一步探讨。
发明内容
[0004]本发明的目的是提供一种利用补骨生髓和补血及补肝肾的方式解决治疗效果不理想问题的治疗白血病的中药组合物。
[0005]本发明所提出的治疗白血病的中药组合物包括以下重量百分比的原料药:胎盘10-50%，狗脊10-50%，补骨脂10-25%，钩藤10-40%，白芍5-30%。其中的胎盘是治疗白血病最佳药物;狗脊具有补肝肾，利关节，主治脊椎疾病的性能;补骨脂具有补骨生髓的性能;钩藤具有治脊髓血液疾病性能；白芍具有补血的性能，通过补肝肾和补骨生髓，以及补血的方式可有效地治疗白血病。
[0006]该组合物的原料药中还包括鸡血藤。鸡血藤也具有补血的性能，对于血脂较低的白血病患者添加鸡血藤进行补血来提高疗效。
[0007]该组合物中各原料药的重量百分比为:胎盘10-50%，狗脊10-50%，补骨脂10-25%，钩藤10-40%，白芍5-30%，鸡血藤5-20%。
[0008]该组合物的原料药中还包括千里光和/或长春花。其中的千里光具有治疗各种眼疾的性能，而长春花具有消肿的性能，对于有眼疾和/或有肿部位的白血病患者添加千里光和/或长春花可提尚疗效。
[0009]该组合物中各原料药的重量百分比为:胎盘10-50%，狗脊10-50%，补骨脂10-25%，钩藤10-40%，白芍5-30%，鸡血藤5-20%，千里光5-20%。
[0010]该组合物中各原料药的重量百分比为:胎盘10-50%，狗脊10-50%，补骨脂10-25%，钩藤10-40%，白芍5-30%，鸡血藤5-20%，千里光5-20%，长春花5-30%。
[0011]该组合物中各原料药的重量百分比为:胎盘10-50%，狗脊10-50%，补骨脂10-25%，钩藤10-40%，白芍5-30%，千里光5-20%，长春花5-30%。
[0012]该组合物中各原料药的重量百分比为:胎盘10-50%，狗脊10-50%，补骨脂10-25%，钩藤10-40%，白芍5-30%，鸡血藤5-20%，长春花5-30%。
[0013]本发明所提出的治疗白血病的中药组合物是以胎盘为主药，内服主药和其它药物组合后对治疗白血病的效果非常理想。据统计，在临床上治愈白血病患者共有23例，其中，有18名白血病患者食用胎盘，狗脊，补骨脂，钩藤和白芍这5种组合的中药，致使白血病痊愈率达到100%;对于有2名血压非常低的白血病患者加了鸡血藤中药，也使2名血压非常低的白血病患者痊愈;对于有3名眼疾和/或有肿部位的白血病患者添加千里光和/或长春花也痊愈。
具体实施方式
[0014] 实施例1
取胎盘50g，狗脊1g，补骨脂1g，钩藤1g，白芍20g。将胎盘烘干研磨后再加入4种中药，白血病患者每天服用三次，每次5克，服用10天痊愈。
[0015] 实施例2
取胎盘1g，狗脊50g，补骨脂1g，钩藤1g，白芍20g。将胎盘烘干研磨后再加入4种中药，白血病患者每天服用三次，每次5克，服用10天痊愈。
[0016] 实施例3
取胎盘30g，狗脊20g，补骨脂10g，钩藤10g，白芍30g。将胎盘烘干研磨后再加入4种中药，白血病患者每天服用三次，每次5克，服用10天痊愈。
[0017] 实施例4
取胎盘20g，狗脊15g，补骨脂25g，钩藤30g，白芍10g。将胎盘烘干研磨后再加入4种中药，白血病患者每天服用三次，每次5克，服用10天痊愈。
[0018] 实施例5
取胎盘50g，狗脊10g，补骨脂10g，钩藤10g，白芍10g，鸡血藤10克。将胎盘烘干研磨后再加入5种中药，白血病患者每天服用三次，每次5克，服用10天痊愈。
[0019] 实施例6
取胎盘1g，狗脊20g，补骨脂15g，钩藤15g，白芍20g，鸡血藤20克。将胎盘烘干研磨后再加入5种中药，白血病患者每天服用三次，每次5克，服用10天痊愈。
[0020] 实施例7
取胎盘30g，狗脊15g，补骨脂25g，钩藤10g，白芍10g，鸡血藤10克。将胎盘烘干研磨后再加入5种中药，白血病患者每天服用三次，每次5克，服用10天痊愈。[0021 ] 实施例8
取胎盘20g，狗脊40g，补骨脂15g，钩藤15g，白芍5g，鸡血藤5克。将胎盘烘干研磨后再加入5种中药，白血病患者每天服用三次，每次5克，服用10天痊愈。
[0022] 实施例9
取胎盘10g，狗脊30g，补骨脂10g，钩藤10g，白芍10g，鸡血藤10克，千里光20克。将胎盘烘干研磨后再加入6种中药，白血病患者每天服用三次，每次5克，服用10天痊愈。
[0023] 实施例10
取胎盘50g，狗脊10g，补骨脂15g，钩藤10g，白芍5g，鸡血藤5克，千里光5克。将胎盘烘干研磨后再加入6种中药，白血病患者每天服用三次，每次5克，服用10天痊愈。
[0024] 实施例11
取胎盘20g，狗脊20g，补骨脂25g，钩藤20g，白芍5g，鸡血藤5克，千里光5克。将胎盘烘干研磨后再加入6种中药，白血病患者每天服用三次，每次5克，服用10天痊愈。
[0025] 实施例12
取胎盘20g，狗脊20g，补骨脂25g，钩藤20g，白芍5g，鸡血藤5克，长春花5克。将胎盘烘干研磨后再加入6种中药，白血病患者每天服用三次，每次5克，服用10天痊愈。
[0026] 实施例13
取胎盘10g，狗脊30g，补骨脂10g，钩藤10g，白芍10g，鸡血藤10克，长春花20克。将胎盘烘干研磨后再加入6种中药，白血病患者每天服用三次，每次5克，服用10天痊愈。
[0027] 实施例14
取胎盘50g，狗脊10g，补骨脂15g，钩藤10g，白芍5g，鸡血藤5克，长春花5克。将胎盘烘干研磨后再加入6种中药，白血病患者每天服用三次，每次5克，服用10天痊愈。
[0028] 实施例15
取胎盘50g，狗脊10g，补骨脂15g，钩藤10g，白芍5g，千里光5克，长春花5克。将胎盘烘干研磨后再加入6种中药，白血病患者每天服用三次，每次5克，服用10天痊愈。
[0029] 实施例16
取胎盘10g，狗脊30g，补骨脂25g，钩藤10g，白芍10g，千里光5克，长春花10克。将胎盘烘干研磨后再加入6种中药，白血病患者每天服用三次，每次5克，服用10天痊愈。
[0030] 实施例17
取胎盘20g，狗脊15g，补骨脂15g，钩藤20g，白芍15g，鸡血藤10克，千里光7克，长春花8克。将胎盘烘干研磨后再加入7种中药，白血病患者每天服用三次，每次5克，服用10天痊愈。
[0031] 实施例18
取胎盘50g，狗脊10g，补骨脂10g，钩藤10g，白芍5g，鸡血藤5克，千里光5克，长春花5克。将胎盘烘干研磨后再加入7种中药，使白血病患者每天服用三次，每次5克，服用10天痊愈。
[0032] 实施例19
取胎盘10g，狗脊50g，补骨脂10g，钩藤10g，白芍5g，鸡血藤5克，千里光5克，长春花5克。将胎盘烘干研磨后再加入7种中药，使白血病患者每天服用三次，每次5克，服用10天痊愈。
[0033] 实施例20
取胎盘30g，狗脊20g，补骨脂20g，钩藤10g，白芍5g，鸡血藤5克，千里光5克，长春花5克。将胎盘烘干研磨后再加入7种中药，使白血病患者每天服用三次，每次5克，服用10天痊愈。
[0034] 实施例21
取胎盘20g，狗脊10g，补骨脂10g，钩藤10g，白芍10g，鸡血藤10克，千里光15克，长春花15克。将胎盘烘干研磨后再加入7种中药，使白血病患者每天服用三次，每次5克，服用10天痊愈。
Claims (8)
1.治疗白血病的中药组合物，其特征在于包括以下重量百分比的原料药:胎盘10-50%，狗脊10-50%，补骨脂10-25%，钩藤10-40%，白芍5-30%。
2.据权利要求1所述的中药组合物，其特征在于:该组合物的原料药中还包括鸡血藤。
3.根据权利要求2所述的中药组合物，其特征在于:该组合物中各原料药的重量百分比为:狗脊10-50%，补骨脂10-25%，钩藤10-40%，白芍5-30%，鸡血藤5-20%。
4.根据权利要求1或2所述的中药组合物，其特征在于:该组合物的原料药中还包括千里光和/或长春花。
5.根据权利要求4所述的中药组合物，其特征在于:该组合物中各原料药的重量百分比为:胎盘10-50%，狗脊10-50%，补骨脂10-25%，钩藤10-40%，白芍5-30%，鸡血藤5-20%，千里光5-20%ο
6.根据权利要求4所述的中药组合物，其特征在于:该组合物中各原料药的重量百分比为:胎盘10-50%，狗脊10-50%，补骨脂10-25%，钩藤10-40%，白芍5-30%，鸡血藤5-20%，千里光5-20%，长春花 5-30%。
7.根据权利要求4所述的中药组合物，其特征在于:该组合物中各原料药的重量百分比为:胎盘10-50%，狗脊10-50%，补骨脂10-25%，钩藤10-40%，白芍5-30%，千里光5-20%，长春花5-30%ο
8.根据权利要求4所述的中药组合物，其特征在于:该组合物中各原料药的重量百分比为:胎盘10-50%，狗脊10-50%，补骨脂10-25%，钩藤10-40%，白芍5-30%，鸡血藤5-20%，长春花5-30%ο
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510912367.5A CN105456421A (zh) | 2015-12-11 | 2015-12-11 | 治疗白血病的中药组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510912367.5A CN105456421A (zh) | 2015-12-11 | 2015-12-11 | 治疗白血病的中药组合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105456421A true CN105456421A (zh) | 2016-04-06 |
Family
ID=55594881
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510912367.5A Pending CN105456421A (zh) | 2015-12-11 | 2015-12-11 | 治疗白血病的中药组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105456421A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105963439A (zh) * | 2016-05-13 | 2016-09-28 | 张国显 | 一种治疗白血病的中药组合物及其制备方法和用途 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103520324A (zh) * | 2013-10-25 | 2014-01-22 | 范银锁 | 一种治疗白血病的中药组合物 |
| CN104435863A (zh) * | 2014-12-25 | 2015-03-25 | 刘海波 | 一种治疗慢性白血病的中药制剂 |
| CN104721281A (zh) * | 2015-03-26 | 2015-06-24 | 井泉涛 | 一种治疗慢性白血病的药物及其制备方法 |
-
2015
- 2015-12-11 CN CN201510912367.5A patent/CN105456421A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103520324A (zh) * | 2013-10-25 | 2014-01-22 | 范银锁 | 一种治疗白血病的中药组合物 |
| CN104435863A (zh) * | 2014-12-25 | 2015-03-25 | 刘海波 | 一种治疗慢性白血病的中药制剂 |
| CN104721281A (zh) * | 2015-03-26 | 2015-06-24 | 井泉涛 | 一种治疗慢性白血病的药物及其制备方法 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105963439A (zh) * | 2016-05-13 | 2016-09-28 | 张国显 | 一种治疗白血病的中药组合物及其制备方法和用途 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100536885C (zh) | 一种治疗脱发病的生发的药物 | |
| CN104337974A (zh) | 治疗崩漏的药物及其制备方法 | |
| CN101062368A (zh) | 治疗肝硬化腹水的中药方剂 | |
| CN102068661A (zh) | 一种治疗女性血淤、血虚、脉沉细型痛经的中药配方 | |
| CN101884761A (zh) | 一种治疗肝硬化、门脉高压的药物 | |
| CN104189774A (zh) | 一种治疗慢性乙型肝炎的中药 | |
| CN103768297A (zh) | 一种用于治疗高脂血症的中药 | |
| CN101129617A (zh) | 治疗肝硬化的中药 | |
| CN1103223C (zh) | 一种用于治疗胆囊炎的中药制剂 | |
| CN105395911A (zh) | 一种治疗脑血栓中药 | |
| CN105456421A (zh) | 治疗白血病的中药组合物 | |
| CN103816431A (zh) | 一种治疗缺铁性贫血的中药组合物 | |
| CN105998645A (zh) | 治疗白发及脱发的中药组合物 | |
| CN101856423A (zh) | 一种治疗月经不调的药物及其制备方法 | |
| CN101732622A (zh) | 治疗闭汗症的中药 | |
| CN104547406A (zh) | 一种治疗心脏病的中药 | |
| CN101683446A (zh) | 一种通脉降脂中药组合物 | |
| CN101112526B (zh) | 按月经周期交替服用的治疗黄褐斑的中药组合物 | |
| CN102614432B (zh) | 一种治疗宫颈炎的中药组合物 | |
| CN105267884A (zh) | 一种用于二尖瓣合并主动脉病变心脏病的药物 | |
| CN105267594A (zh) | 一种提高精子活性的中药配方 | |
| CN105031321A (zh) | 一种治疗骨肿瘤的中药 | |
| CN105267855A (zh) | 一种治疗骨折的中成药 | |
| CN104707091A (zh) | 治疗冠心病的中药及其制备方法 | |
| CN103550507A (zh) | 一种治疗白血病的中药 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160406 |